Go Pro
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel Free OPTI Stock Alerts

OptiBiotix Health (OPTI) Competitors

OptiBiotix Health logo
GBX 5.64 -0.01 (-0.21%)
As of 08/21/2026 10:10 AM Eastern
Compare

OPTI vs. HALO, MXC, RGT, CEL, and IDP

Should you buy OptiBiotix Health stock or one of its competitors? OptiBiotix Health's main competitors and comparable companies include HaloSource (HALO), Argent BioPharma (MXC), Argent BioPharma (RGT), Celadon Pharmaceuticals (CEL), and InnovaDerma (IDP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does OptiBiotix Health compare to HaloSource?

HaloSource (LON:HALO) and OptiBiotix Health (LON:OPTI) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

HaloSource has higher earnings, but lower revenue than OptiBiotix Health. HaloSource is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HaloSourceN/AN/AN/A-£1.49N/A
OptiBiotix Health£1.17M4.99-£3.09M-£3.84N/A

HaloSource has a net margin of 0.00% compared to OptiBiotix Health's net margin of -333.62%. HaloSource's return on equity of 0.00% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
HaloSourceN/A N/A N/A
OptiBiotix Health -333.62%-52.92%-13.93%

0.4% of OptiBiotix Health shares are owned by institutional investors. 26.8% of OptiBiotix Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, OptiBiotix Health had 1 more articles in the media than HaloSource. MarketBeat recorded 1 mentions for OptiBiotix Health and 0 mentions for HaloSource. OptiBiotix Health's average media sentiment score of 0.75 beat HaloSource's score of 0.00 indicating that OptiBiotix Health is being referred to more favorably in the news media.

Company Overall Sentiment
HaloSource Neutral
OptiBiotix Health Positive

Summary

OptiBiotix Health beats HaloSource on 6 of the 10 factors compared between the two stocks.

How does OptiBiotix Health compare to Argent BioPharma?

OptiBiotix Health (LON:OPTI) and Argent BioPharma (LON:MXC) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

OptiBiotix Health has higher earnings, but lower revenue than Argent BioPharma. OptiBiotix Health is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OptiBiotix Health£1.17M4.99-£3.09M-£3.84N/A
Argent BioPharma£1.32M0.00-£17.02M-£1.66N/A

Argent BioPharma has a net margin of 0.00% compared to OptiBiotix Health's net margin of -333.62%. Argent BioPharma's return on equity of 0.00% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
OptiBiotix Health-333.62% -52.92% -13.93%
Argent BioPharma N/A N/A -58.96%

0.4% of OptiBiotix Health shares are held by institutional investors. Comparatively, 1.2% of Argent BioPharma shares are held by institutional investors. 26.8% of OptiBiotix Health shares are held by insiders. Comparatively, 8.2% of Argent BioPharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

OptiBiotix Health has a beta of 1.824, indicating that its stock price is 82% more volatile than the broader market. Comparatively, Argent BioPharma has a beta of 1.03, indicating that its stock price is 3% more volatile than the broader market.

In the previous week, OptiBiotix Health had 1 more articles in the media than Argent BioPharma. MarketBeat recorded 1 mentions for OptiBiotix Health and 0 mentions for Argent BioPharma. OptiBiotix Health's average media sentiment score of 0.75 beat Argent BioPharma's score of 0.00 indicating that OptiBiotix Health is being referred to more favorably in the media.

Company Overall Sentiment
OptiBiotix Health Positive
Argent BioPharma Neutral

Summary

OptiBiotix Health beats Argent BioPharma on 7 of the 12 factors compared between the two stocks.

How does OptiBiotix Health compare to Argent BioPharma?

Argent BioPharma (LON:RGT) and OptiBiotix Health (LON:OPTI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk.

OptiBiotix Health has a net margin of -333.62% compared to Argent BioPharma's net margin of -1,967.38%. Argent BioPharma's return on equity of 279.26% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Argent BioPharma-1,967.38% 279.26% -108.57%
OptiBiotix Health -333.62%-52.92%-13.93%

1.1% of Argent BioPharma shares are held by institutional investors. Comparatively, 0.4% of OptiBiotix Health shares are held by institutional investors. 17.8% of Argent BioPharma shares are held by company insiders. Comparatively, 26.8% of OptiBiotix Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

OptiBiotix Health has higher revenue and earnings than Argent BioPharma. OptiBiotix Health is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Argent BioPharmaN/AN/A-£17.53M-£0.24N/A
OptiBiotix Health£1.17M4.99-£3.09M-£3.84N/A

Argent BioPharma has a beta of 1.05, meaning that its stock price is 5% more volatile than the broader market. Comparatively, OptiBiotix Health has a beta of 1.824, meaning that its stock price is 82% more volatile than the broader market.

In the previous week, OptiBiotix Health had 1 more articles in the media than Argent BioPharma. MarketBeat recorded 1 mentions for OptiBiotix Health and 0 mentions for Argent BioPharma. OptiBiotix Health's average media sentiment score of 0.75 beat Argent BioPharma's score of 0.00 indicating that OptiBiotix Health is being referred to more favorably in the news media.

Company Overall Sentiment
Argent BioPharma Neutral
OptiBiotix Health Positive

Summary

OptiBiotix Health beats Argent BioPharma on 8 of the 12 factors compared between the two stocks.

How does OptiBiotix Health compare to Celadon Pharmaceuticals?

OptiBiotix Health (LON:OPTI) and Celadon Pharmaceuticals (LON:CEL) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation and dividends.

OptiBiotix Health has a beta of 1.824, suggesting that its stock price is 82% more volatile than the broader market. Comparatively, Celadon Pharmaceuticals has a beta of -0.26, suggesting that its stock price is 126% less volatile than the broader market.

OptiBiotix Health has higher revenue and earnings than Celadon Pharmaceuticals. Celadon Pharmaceuticals is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OptiBiotix Health£1.17M4.99-£3.09M-£3.84N/A
Celadon Pharmaceuticals£123.38K66.61-£4.97M-£7.98N/A

In the previous week, OptiBiotix Health had 1 more articles in the media than Celadon Pharmaceuticals. MarketBeat recorded 1 mentions for OptiBiotix Health and 0 mentions for Celadon Pharmaceuticals. OptiBiotix Health's average media sentiment score of 0.75 beat Celadon Pharmaceuticals' score of 0.00 indicating that OptiBiotix Health is being referred to more favorably in the media.

Company Overall Sentiment
OptiBiotix Health Positive
Celadon Pharmaceuticals Neutral

0.4% of OptiBiotix Health shares are owned by institutional investors. Comparatively, 10.7% of Celadon Pharmaceuticals shares are owned by institutional investors. 26.8% of OptiBiotix Health shares are owned by insiders. Comparatively, 65.1% of Celadon Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

OptiBiotix Health has a net margin of -333.62% compared to Celadon Pharmaceuticals' net margin of -9,520.00%. OptiBiotix Health's return on equity of -52.92% beat Celadon Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
OptiBiotix Health-333.62% -52.92% -13.93%
Celadon Pharmaceuticals -9,520.00%-131.82%-34.40%

Summary

OptiBiotix Health beats Celadon Pharmaceuticals on 10 of the 13 factors compared between the two stocks.

How does OptiBiotix Health compare to InnovaDerma?

InnovaDerma (LON:IDP) and OptiBiotix Health (LON:OPTI) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

In the previous week, OptiBiotix Health had 1 more articles in the media than InnovaDerma. MarketBeat recorded 1 mentions for OptiBiotix Health and 0 mentions for InnovaDerma. OptiBiotix Health's average media sentiment score of 0.75 beat InnovaDerma's score of 0.00 indicating that OptiBiotix Health is being referred to more favorably in the news media.

Company Overall Sentiment
InnovaDerma Neutral
OptiBiotix Health Positive

0.4% of OptiBiotix Health shares are held by institutional investors. 26.8% of OptiBiotix Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

InnovaDerma has higher revenue and earnings than OptiBiotix Health. OptiBiotix Health is trading at a lower price-to-earnings ratio than InnovaDerma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InnovaDerma£9.82M0.00N/A-£7.50N/A
OptiBiotix Health£1.17M4.99-£3.09M-£3.84N/A

InnovaDerma has a net margin of 0.00% compared to OptiBiotix Health's net margin of -333.62%. InnovaDerma's return on equity of 0.00% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
InnovaDermaN/A N/A N/A
OptiBiotix Health -333.62%-52.92%-13.93%

Summary

OptiBiotix Health beats InnovaDerma on 6 of the 10 factors compared between the two stocks.

Get OptiBiotix Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPTI vs. The Competition

Export
MetricOptiBiotix HealthPharmaceuticals IndustryHealthcare SectorLON Exchange
Market Cap£5.84M£12.57B£7.37B£2.54B
Dividend YieldN/A2.61%2.53%6.17%
P/E Ratio-1.47789.80272.60367.57
Price / Sales4.99764.53624.3383,481.74
Price / Cash8.6896.7778.6227.89
Price / Book0.7211.8913.057.19
Net Income-£3.09M£2.81B£3.47B£5.89B
7 Day Performance-3.62%1.77%2.09%0.30%
1 Month Performance2.32%3.85%6.64%3.31%
1 Year Performance-52.57%6.56%25.02%22.13%

OptiBiotix Health Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPTI
OptiBiotix Health
N/AGBX 5.64
-0.2%		N/A-52.6%£5.84M£1.17MN/A1
HALO
HaloSource
N/AGBX 9.28
+0.3%		N/AN/A£10.27MN/AN/A390
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32MN/A5
RGT
Argent BioPharma
N/AN/AN/AN/A£8.31MN/AN/AN/A
CEL
Celadon Pharmaceuticals
N/AGBX 13.40
flat		N/AN/A£8.22M£123.38KN/A2,780

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:OPTI) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel